Testosterone research brings new hope for cancer patients

Approximately 20 percent of cancer related deaths are attributed to the syndrome of cachexia. Dr. Melinda Sheffield-Moore, professor and head of the Department of Health and Kinesiology, along with researchers at University of Texas Medical Branch, recently published research in the Journal of Cachexia, Sarcopenia and Muscle showing that the hormone testosterone is effective at combatting cachexia in cancer patients and improving quality of life.

Go to Source

(Visited 7 times, 1 visits today)

Site Footer

Sliding Sidebar